Protective Effect of Safranal, a Constituent of Crocus sativus, on Quinolinic Acid-induced Oxidative Damage in Rat Hippocampus

Publish Year: 1392
نوع سند: مقاله ژورنالی
زبان: English
View: 147

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-16-1_008

تاریخ نمایه سازی: 4 آبان 1400

Abstract:

Objective(s): Quinolinic acid (QA)-mediated excitotoxicity has been widely used as a model for studying neurodegenerative disorders. Recent studies suggested that saffron (Crocus sativus) or its active metabolite, i.e. safranal, exerts pharmacological actions on central nervous system including anxiolytic, anticonvulsant, and neuroprotective properties. The present study aimed to investigate the effect safranal pretreatment on QA-induced oxidative damage in rat hippocampus. Materials and Methods: Under anesthesia, a guide cannula was stereotaxically inserted into left ventral hippocampus of rats. The rats were then given either saline or safranal (۷۲.۷۵, ۱۴۵.۵, and ۲۹۱ mg/kg, IP) ۳۰ min before administration of QA (۳۰۰ nmol, intrahippocampal injection). The markers of oxidative stress including thiobarbituric acid reactive substances (TBARS, as an index of lipid preoxidation), total sulfhydryl groups, antioxidant capacity of hippocampus (using FRAP assay), and oxidative DNA damage (%tail DNA, using comet assay) were measured in hippocampus. Results: The QA induced a significant increase in TBARS levels and %tail DNA and remarkable decrease in antioxidant power (FRAP value) and total sulfhydryl content of hippocampus, in comparison with control animals. Systemic administration of safranal (۲۹۱ mg/kg, IP), effectively and dose-dependently decreased the QA-induced lipid peroxidation (P<۰.۰۰۱) and oxidative DNA damage (P<۰.۰۰۱). Safranal also prevented the decrease of hippocampal thiol redox and antioxidant status (P<۰.۰۰۱) produced by QA. Conclusion: Safranal have protective effects on different markers of oxidative damage in hippocampal tissue following QA administration. Our findings might raise a possibility of potential therapeutic application of safranal for preventing and treating neurodegenerative disorders such as Alzheimer’s disease.

Authors

Hamid Reza Sadeghnia

۱Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran ۲Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mina Kamkar

۱Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Elham Assadpour

۱Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Taher Boroushaki

۱Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran ۲Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Ahmad Ghorbani

۲Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: ...
  • Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Eur ...
  • Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, ...
  • Myint AM. Kynurenines: from the perspective of major psychiatric disorders. ...
  • Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev ...
  • Zadori D, Klivenyi P, Vamos E, Fulop F, Toldi J, ...
  • Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease ...
  • Pérez-De La Cruz V, Carrillo-Mora P, Santamaría A. Quinolinic Acid, ...
  • Sas K, Robotka H, Toldi J, Vécsei L. Mitochondria, metabolic ...
  • Tavares RG, Tasca CI, Santos CE, Alves LB, Porciúncula LO, ...
  • Tavares RG, Schmidt AP, Abud J, Tasca CI, Souza DO. ...
  • Vezzani A, Forloni GL, Serafini R, Rizzi M, Samanin R. ...
  • Dairam A, Chetty P, Daya S. Non-steroidal anti-inflammatory agents, tolmetin ...
  • Tarantilis PA, Tsoupras G, Polissiou M. Determination of saffron (Crocus ...
  • Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of ...
  • Amin B, Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts ...
  • Hosseinzadeh H, Shariaty V. Anti-nociceptive effect of safranal, a constituent ...
  • Fukui H, Toyoshima K, Komaki R. Psychological and neuroendocrinological effects ...
  • Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus ...
  • Liu Z, Xu XH, Liu TY, Hong ZY, Urade Y, ...
  • Hosseinzadeh H, Sadeghnia HR. Protective effect of safranal on pentylenetetrazol-induced ...
  • Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus ...
  • Karimi GR, Hosseinzadeh H, Khalegh Panah P. Study of antidepressant ...
  • Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, ...
  • Hooshmandi Z, Rohani AH, Eidi A, Fatahi Z, Golmanesh L, ...
  • Rezaee R, Hosseinzadeh H. Safranal: from an aromatic natural product ...
  • Paxions G, Watson C. The Rat Brain. San Diego : ...
  • Schwarcz R, Brush GS, Foster AC, French ED. Seizure activity ...
  • Benzie IFF, Strain J. The ferric reducing ability of plasma ...
  • Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys ۱۹۵۹; ۸۲:۷۰-۷۷ ...
  • Buege JA, Aust SD. Microsomal lipid peroxidation. Method Enzymol ۱۹۷۸; ...
  • Silva JP, Areias FM, Proença FM, Coutinho OP. Oxidative stress ...
  • Hosseinzadeh H, Sadeghnia HR. Effect of safranal, a constituent of ...
  • da Rocha MD, Viegas FP, Campos HC, Nicastro PC, Fossaluzza ...
  • Colle D, Hartwig JM, Soares FA, Farina M. Probucol modulates ...
  • Kalonia H, Mishra J, Kumar A. Targeting neuro-inflammatory cytokines and ...
  • Leipnitz G, Schumacher C, Scussiato K, Dalcin KB, Wannmacher CM, ...
  • Dizdaroglu M, Jaruga P. Mechanisms of free radical-induced damage to ...
  • Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress ...
  • Ganzella M, Jardim FM, Boeck CR, Vendite D. Time course ...
  • Pláteník J, Stopka P, Vejrazka M, Stípek S. Quinolinic acid-iron(ii) ...
  • Halliwell B. Oxidative stress and neurodegeneration: where are we now? ...
  • Hariri AT, Moallem SA, Mahmoudi M, Hosseinzadeh H. The effect ...
  • Bharti S, Golechha M, Kumari S, Siddiqui KM, Arya DS. ...
  • Hosseinzadeh H, Sadeghnia HR, Rahimi A. Effect of safranal on ...
  • Brickell KL, Nicholson LFB, Waldvogel HJ, Faull RLM. Chemical and ...
  • Santamaría A, Salvatierra-Sánchez R, Vázquez-Román B, Santiago-López D, Villeda-Hernández J, ...
  • Ryu JK, Choi HB, McLarnona JG. Peripheral benzodiazepine receptor ligand ...
  • Ganzella M, Faraco RB, Almeida RF, Fernandes VF, Souza DO. ...
  • Sadeghnia HR, Cortez MA, Liu D, Hosseinzadeh H, Snead OC. ...
  • Iadecola C, Anrather J. The immunology of stroke: from mechanisms ...
  • Rogers J. Inflammation as a pathogenic mechanism in Alzheimer’s disease. ...
  • Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ. ...
  • Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: ...
  • Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Eur ...
  • Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, ...
  • Myint AM. Kynurenines: from the perspective of major psychiatric disorders. ...
  • Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev ...
  • Zadori D, Klivenyi P, Vamos E, Fulop F, Toldi J, ...
  • Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease ...
  • Pérez-De La Cruz V, Carrillo-Mora P, Santamaría A. Quinolinic Acid, ...
  • Sas K, Robotka H, Toldi J, Vécsei L. Mitochondria, metabolic ...
  • Tavares RG, Tasca CI, Santos CE, Alves LB, Porciúncula LO, ...
  • Tavares RG, Schmidt AP, Abud J, Tasca CI, Souza DO. ...
  • Vezzani A, Forloni GL, Serafini R, Rizzi M, Samanin R. ...
  • Dairam A, Chetty P, Daya S. Non-steroidal anti-inflammatory agents, tolmetin ...
  • Tarantilis PA, Tsoupras G, Polissiou M. Determination of saffron (Crocus ...
  • Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of ...
  • Amin B, Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts ...
  • Hosseinzadeh H, Shariaty V. Anti-nociceptive effect of safranal, a constituent ...
  • Fukui H, Toyoshima K, Komaki R. Psychological and neuroendocrinological effects ...
  • Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus ...
  • Liu Z, Xu XH, Liu TY, Hong ZY, Urade Y, ...
  • Hosseinzadeh H, Sadeghnia HR. Protective effect of safranal on pentylenetetrazol-induced ...
  • Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus ...
  • Karimi GR, Hosseinzadeh H, Khalegh Panah P. Study of antidepressant ...
  • Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, ...
  • Hooshmandi Z, Rohani AH, Eidi A, Fatahi Z, Golmanesh L, ...
  • Rezaee R, Hosseinzadeh H. Safranal: from an aromatic natural product ...
  • Paxions G, Watson C. The Rat Brain. San Diego : ...
  • Schwarcz R, Brush GS, Foster AC, French ED. Seizure activity ...
  • Benzie IFF, Strain J. The ferric reducing ability of plasma ...
  • Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys ۱۹۵۹; ۸۲:۷۰-۷۷ ...
  • Buege JA, Aust SD. Microsomal lipid peroxidation. Method Enzymol ۱۹۷۸; ...
  • Silva JP, Areias FM, Proença FM, Coutinho OP. Oxidative stress ...
  • Hosseinzadeh H, Sadeghnia HR. Effect of safranal, a constituent of ...
  • da Rocha MD, Viegas FP, Campos HC, Nicastro PC, Fossaluzza ...
  • Colle D, Hartwig JM, Soares FA, Farina M. Probucol modulates ...
  • Kalonia H, Mishra J, Kumar A. Targeting neuro-inflammatory cytokines and ...
  • Leipnitz G, Schumacher C, Scussiato K, Dalcin KB, Wannmacher CM, ...
  • Dizdaroglu M, Jaruga P. Mechanisms of free radical-induced damage to ...
  • Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress ...
  • Ganzella M, Jardim FM, Boeck CR, Vendite D. Time course ...
  • Pláteník J, Stopka P, Vejrazka M, Stípek S. Quinolinic acid-iron(ii) ...
  • Halliwell B. Oxidative stress and neurodegeneration: where are we now? ...
  • Hariri AT, Moallem SA, Mahmoudi M, Hosseinzadeh H. The effect ...
  • Bharti S, Golechha M, Kumari S, Siddiqui KM, Arya DS. ...
  • Hosseinzadeh H, Sadeghnia HR, Rahimi A. Effect of safranal on ...
  • Brickell KL, Nicholson LFB, Waldvogel HJ, Faull RLM. Chemical and ...
  • Santamaría A, Salvatierra-Sánchez R, Vázquez-Román B, Santiago-López D, Villeda-Hernández J, ...
  • Ryu JK, Choi HB, McLarnona JG. Peripheral benzodiazepine receptor ligand ...
  • Ganzella M, Faraco RB, Almeida RF, Fernandes VF, Souza DO. ...
  • Sadeghnia HR, Cortez MA, Liu D, Hosseinzadeh H, Snead OC. ...
  • Iadecola C, Anrather J. The immunology of stroke: from mechanisms ...
  • Rogers J. Inflammation as a pathogenic mechanism in Alzheimer’s disease. ...
  • Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ. ...
  • نمایش کامل مراجع